The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin-Reference-Cited by-同舟云学术

The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin

Published:2011-04 Issue:4 Volume:6 Page:661-670
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Srirangam Anjaiah,Milani Monica,Mitra Ranjana,Guo Zhijun,Rodriguez Mariangellys,Kathuria Hitesh,Fukuda Seiji,Rizzardi Anthony,Schmechel Stephen,Skalnik David G.,Pelus Louis M.,Potter David A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference60 articles.

1. Inhibition of angiogenesis by the antifungal drug itraconazole;Chong;ACS Chem Biol,2007

2. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo;Ikezoe;Cancer Res,2004

3. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer;Srirangam;Clin Cancer Res,2006

4. Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells;Kumar;Mol Cancer,2009

5. Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma;Pati;Blood,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of human DNA alkylation damage repair enzyme ALKBH2 by HIV protease inhibitor ritonavir;DNA Repair;2024-09

2. Inference of gene regulatory networks based on directed graph convolutional networks;Briefings in Bioinformatics;2024-05-23

3. Survivin in lung cancer: a potential target for therapy and prevention—a narrative review;Translational Lung Cancer Research;2024-02

4. Synthesis, molecular docking analysis and in vitro evaluation of new heterocyclic hybrids of 4-aza-podophyllotoxin as potent cytotoxic agents;RSC Advances;2024

5. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024